2002 Fulbright Lifetime Achievement Medal Recipient

Named Chief Executive Officer of GlaxoSmithKline in December 2000 with the merger of SmithKline Beecham and Glaxo Wellcome, Dr. Garnier leads one of the world’s largest pharmaceutical companies. He holds a doctorate in pharmacology and a master’s degree in pharmaceutical science from the University of Louis Pasteur in France. As a Fulbright fellow, he earned a master’s of business administration degree at Stanford University in 1974. Dr. Garnier serves on the boards of directors of the United Technologies Corporation and the Eisenhower Exchange Fellowships, Inc. In January 1997, he was selected by President Chirac of France to receive the Chevalier de la Légion d’Honneur, an honor created in 1802 by French Emperor Napoleon I to recognize civilian or military accomplishments. Dr. Garnier is also recipient of the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.